SCM
ZSAN

Stonepine Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Stonepine Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,714
Closed -$1.01M – 33
2018
Q1 		$1.01M Buy
+5,714
New +$1.91M 0.54% 24

Other funds holding ZSAN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Stonepine Capital Management's ZSAN Position: Q2 2018 in Review

Stonepine Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2018, closing a stake of 5,714 shares — an estimated $1.01M sold.

Stonepine Capital Management first reported a position in ZSAN in Q1 2018 and held it in 1 quarter. The position peaked at $1.01M in Q1 2018. 25 funds tracked by Wall St. Rank hold ZSAN as of Q2 2018.

  • Stonepine Capital Management reported no remaining Zosano Pharma Corporation position as of Q2 2018 after selling out during the quarter.
  • Stonepine Capital Management sold 5,714 Zosano Pharma Corporation shares in Q2 2018, an estimated $1.01M.
  • Stonepine Capital Management first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 1 quarter.
  • Stonepine Capital Management's Zosano Pharma Corporation position peaked at $1.01M in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2018.

Based on Stonepine Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.